Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+5.88%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$949M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,161
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
+$539M |
| 2 |
CSX Corp
CSX
|
+$201M |
| 3 |
Ally Financial
ALLY
|
+$195M |
| 4 |
NetEase
NTES
|
+$190M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$168M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$279M |
| 2 |
CVS Health
CVS
|
+$239M |
| 3 |
McKesson
MCK
|
+$210M |
| 4 |
Mastercard
MA
|
+$204M |
| 5 |
Molson Coors Class B
TAP
|
+$197M |
Sector Composition
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.75% |
| 4 | Financials | 10.45% |
| 5 | Energy | 9.35% |
